ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 49 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,005 | +181.8% | 12,163 | +349.8% | 0.00% | – |
| Q1 2023 | $25,553 | -25.8% | 2,704 | -16.4% | 0.00% | – |
| Q4 2022 | $34,453 | +165.0% | 3,235 | +76.2% | 0.00% | – |
| Q3 2022 | $13,000 | – | 1,836 | +5000.0% | 0.00% | – |
| Q2 2022 | $0 | – | 36 | -28.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 50 | -66.7% | 0.00% | – |
| Q3 2021 | $1,000 | -95.5% | 150 | -94.7% | 0.00% | – |
| Q2 2021 | $22,000 | +2100.0% | 2,843 | +1795.3% | 0.00% | – |
| Q1 2021 | $1,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 37,500 | $225,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 73,366 | $441,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 56,673 | $341,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $60,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $535,000 | 0.01% |
| EMFO, LLC | 1,666 | $10,000 | 0.01% |
| Virtu Financial LLC | 14,020 | $84,000 | 0.01% |
| Retirement Group, LLC | 1,129 | $17,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 86,866 | $522,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $4,000 | 0.00% |